drugset / Trial / NCT00640549

Atorvastatin and LDL Profile in Non-Insulin Dependent Diabetes Mellitus

NCT00640549 ↗

Phase 4 Terminated 41 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The study will investigate the effects of atorvastatin on the concentrations of small, dense LDL and HDL subfractions in patients with diabetes and the underlying mechanisms of these effects.

Timeline

Start
2003-03
Primary completion
—
Completion
2004-10

Outcome

Outcome not reported

Stopped: “See termination reason in detailed description.”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atorvastatin Small molecule 20 mg Oral